4th Quarter - Report

ATLAS CROSSING LLC for RECURSION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

Issues related to artificial intelligence and machine learning. Issues related to infectious diseases. Issues related to drug discovery.

LobbyistCovered position, as disclosed
ALEX BOLTON Chief of Staff, Rep. Nicole Malliotakis
CHRISTOPHER W EDDOWES —
SEAN JOYCE —
CHRISTOPHER KIM Intern, U.S. Rep. Bill Huizenga
ALEXIS OBERG —
CHRISTOPHER SWEET —

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Office of Science & Technology Policy (OSTP)

Budget/Appropriations BUD

Issues related to funding for platform technologies used for drug discovery. H.R.9029/S.4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.

LobbyistCovered position, as disclosed
ALEX BOLTON —
CHRISTOPHER W EDDOWES —
SEAN JOYCE —
CHRISTOPHER KIM —
ALEXIS OBERG —
CHRISTOPHER SWEET —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4942 (118th), H.R. 9029 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.